Navigation Links
Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
Date:2/27/2009

l storage disorders. Under the agreement, Shire received commercial rights outside of the United States. Amicus retains all U.S. rights.

About Pompe Disease

Pompe disease affects an estimated 5,000-10,000 individuals world-wide and is clinically heterogeneous in the age of onset, the extent of organ involvement, and the rate of progression. The early onset form of the disease is the most severe, progresses most rapidly, and is characterized by musculoskeletal, pulmonary, gastrointestinal, and cardiac symptoms that usually lead to death from cardio-respiratory failure between 1 and 2 years of age. The late onset form of the disease begins between childhood and adulthood and has a slower rate of progression that is characterized by musculoskeletal and pulmonary symptoms that usually lead to progressive muscle weakness and respiratory insufficiency. A high majority of patients have the late onset form of the disease. The U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for the active ingredient in AT2220 in the United States.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

Forward-Looking Statements


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015   Sanofi ... life sciences team at Google announced today that they ... with type 1 and type 2 diabetes. The collaboration ... expertise in analytics, miniaturized electronics and low power chip ... care by developing new tools that bring together many ...
(Date:8/31/2015)... Aug. 31, 2015  AMRI (NASDAQ: AMRI ... strategic collaboration focused on the development, manufacture and ... ingredients, ("APIs"). The collaboration combines Saneca,s strength in ... in developing and manufacturing controlled substance APIs with ... transfer processes into these facilities. The collaboration will ...
(Date:8/31/2015)...  QT Vascular Ltd., together with its subsidiaries ... its subsidiaries, the "Group"), a global company engaged ... therapeutic solutions for the minimally invasive treatment of ... the below-the-knee ("BTK") cohort of patients in the ... on August 15, 2015 at the 5th Annual ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... Calif., Jan. 18, 2011 Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today that Eric Pauwels has joined Accuray ... 17, 2011. Pauwels is a global industry leader ... top-tier U.S. and European bio-pharmaceutical companies. He has successfully developed ...
... today that TMC , a global, integrated media ... has named the Cardiocom Commander® Telehealth System as a ... Cardiocom,s Commander Telehealth System provides an opportunity ... patient through an interactive "health check" that includes the ...
Cached Medicine Technology:Accuray Hires Chief Marketing Officer 2Accuray Hires Chief Marketing Officer 3Accuray Hires Chief Marketing Officer 4Cardiocom® Receives the 2010 TMCnet Smart Health Excellence Award for its Telehealth System 2Cardiocom® Receives the 2010 TMCnet Smart Health Excellence Award for its Telehealth System 3
(Date:8/31/2015)... , ... August 31, 2015 , ... ... giving potential patients the resources they need to have a successful cosmetic procedure; ... certified plastic surgeons; Cosmetic Town Journal is always ready to help. , It ...
(Date:8/31/2015)... ... , ... Dental clinicians from Newcastle University, United Kingdom, visited ... more about its integrated approach to diabetes care. , Philip Preshaw, BDS, PhD, ... at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical Research ...
(Date:8/31/2015)... ... 2015 , ... When it comes to undergoing a hair transplant, most patients have donor hair ... more volume to the hair on top of the scalp, as well as filling in ... of donor hair on other areas of their head. , What about patients who have ...
(Date:8/31/2015)... ... 31, 2015 , ... India Network Foundation, a non-profit US-based ... which summarizes all available plans, plan maximums, pre-existing condition coverage limits and deductible ... India Network members make an informed decision regarding the care they want for ...
(Date:8/31/2015)... ... 31, 2015 , ... The Lisle family law firm of Momkus McCluskey, ... by his peers to earn a “Leading Lawyers” distinction. , The ... state of Illinois. The nomination process is based on statewide peer survey nominations and ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2
... Perspectives of People Living with Rheumatoid, Arthritis ... of 30 Years, HORSHAM, Pa., July 15 ... by people diagnosed with,rheumatoid arthritis (RA), according to ... surveys. According to the GeneRAtions(TM),surveys -- one of ...
... ,California Budget Challenge, SACRAMENTO, Calif., July 29 ... nonpartisan organization Next 10 has just released,a newly ... that voters,can try their hand at dealing with ... newly re-released 2008 Budget Challenge, an online,interactive educational ...
... Insulet Corporation,(Nasdaq: PODD ), the leader in ... plans to release its financial results,for the second quarter ... of,the financial markets., Insulet will also host a ... 12, 2008 to discuss its second quarter 2008 financial,results. ...
... Inc. (AMI), the,leading publisher of celebrity journalism and health ... for the conference call it,plans to hold at 1:00 ... of,the senior subordinated notes of its American Media Operations, ... be to update,noteholders with respect to its business., ...
... 28,000 Infants Died in 2005, WHITE PLAINS, N.Y., ... accounted for a growing proportion of infant deaths,according to ... Statistics (NCHS)., Babies who died of preterm-related causes ... from 34.6 percent in 2000, according to "Infant,Mortality Statistics ...
... population-based breast cancer screening program in Norway and an ... in Vermont are equally sensitive for detecting cancer, researchers ... Journal of the National Cancer Institute . But ... Norway. , Breast cancer screening in the United States ...
Cached Medicine News:Health News:New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through 'Generations' 2Health News:New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through 'Generations' 3Health News:New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through 'Generations' 4Health News:New Survey Findings Reveal Emotional and Physical Toll of Rheumatoid Arthritis and the Advancement of Treatment Through 'Generations' 5Health News:As Budget Stalemate Wears On - Voters Can Set Their Own Priorities 2Health News:Insulet Corporation to Report Second Quarter 2008 Financial Results on Tuesday, August 12, 2008 2Health News:Preterm Birth Contributes to Growing Number of Infant Deaths 2Health News:2 different breast cancer screening strategies are equally effective 2
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: